Most linked-to categories
More actions
Showing below up to 50 results in range #51 to #100.
- Monoamine Oxidase Inhibitors (MAOIs) (15 members)
- Synthetic opioids (14 members)
- Botanicals (14 members)
- Mood stabilizers (13 members)
- Pharmacogenomics (13 members)
- NSAIDs (13 members)
- Arylcyclohexylamines (13 members)
- Anticholinergics (anti-muscarinic) (12 members)
- Glucocorticoids (11 members)
- Corticosteroids (11 members)
- Anti-addiction agents (11 members)
- Drug-metabolizing enzymes (11 members)
- Sodium channel blockers (11 members)
- Pharmacopedia policy (10 members)
- Western clinical herbs (10 members)
- Fixed-dose combinations (10 members)
- Opioid analgesics (10 members)
- Anti-infectives (10 members)
- Antibacterials (10 members)
- Lipid-lowering agents (10 members)
- Second-generation neuroleptics (10 members)
- Anticonvulsants (10 members)
- Digestive herbs (9 members)
- Endocrine therapy (9 members)
- Immunosuppressants (9 members)
- Cardiovascular agents (9 members)
- 2C-x series (9 members)
- Semisynthetic opioids (9 members)
- Synthetic Cannabinoids (9 members)
- Antihyperglycemic agents (8 members)
- Methylphenidates (Phenidates) (8 members)
- Barbiturates (8 members)
- Anti-Dementia Medicines (8 members)
- H1 receptor antagonists (7 members)
- Sleep aids (7 members)
- Schedule IV controlled substances (7 members)
- Schedule II controlled substances (7 members)
- Opioid antagonists (7 members)
- US legal status (7 members)
- Poeia (7 members)
- Books (7 members)
- Daimonica (7 members)
- Caffeine plants (7 members)
- NBOMe / NBOH series (7 members)
- Phenothiazines (7 members)
- Racetams (7 members)
- Inhalational Anesthetics (7 members)
- General (IV) Anesthetics (7 members)
- Tricyclic Antidepressants (TCAs) (7 members)
- Templates (7 members)